Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms [0.03%]
在实际操作中切换到高级混合闭环系统可改善成人1型糖尿病患者的低血糖感知能力及代谢控制，尤其是那些对低血糖症状感知受损的患者
Lía Nattero-Chávez,Edurne Lecumberri Pascual,Esther De La Calle et al.
Lía Nattero-Chávez et al.
Aims: To evaluate the efficacy of an advance closed-loop (AHCL) system in restoring awareness of hypoglycemia in patients with type 1 diabetes (T1D). Meth...
High prevalence with no gender difference of likely eating disorders in type 1 mellitus diabetes on insulin pump [0.03%]
1型糖尿病使用胰岛素泵治疗的患者饮食紊乱患病率高但无性别差异
Laura Albaladejo,Pauline Périnet-Marquet,Claire Buis et al.
Laura Albaladejo et al.
Aim: The aim of this study was to determine the prevalence of likely eating disorders and insulin misuse in a prospective cohort of adults with type 1 diabetes mellitus (T1DM) treated with insulin pump therapy. ...
Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea [0.03%]
韩国2型糖尿病患者抗糖尿病药物与房颤发病率之间的关系：一项全国队列研究
Sunyoung Kim,So Young Park,Bongseong Kim et al.
Sunyoung Kim et al.
Background: Although diabetes is a risk factor for atrial fibrillation (AF), studies on the AF risk according to the antidiabetic drugs are lacking. This study evaluated the effects of antidiabetic drugs on AF incidence i...
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data [0.03%]
基于真实世界数据的模型成本效益分析：与长效胰岛素相比，GLP-1受体激动剂对伴或不伴有心血管或慢性肾脏疾病2型糖尿病患者的治疗价值如何？
Chun-Ting Yang,Wen-Yu Yao,Huang-Tz Ou et al.
Chun-Ting Yang et al.
Aims: To evaluate the cost-effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) in patients with type 2 diabetes (T2D) using real-world data. ...
Hypertriglyceridemic waist phenotype, hypertriglyceridemic waist-to-height ratio phenotype and abnormal glucose metabolism in adolescents [0.03%]
高三酰甘油腰围表型、高三酰甘油腰高比表型与青少年异常糖代谢关系
Na Lu,Gang Cheng,Chun-Ming Ma et al.
Na Lu et al.
Objective: The purpose of this study was to evaluate the relationship between hypertriglyceridemic waist (HW) phenotype,hypertriglyceridemic waist-to-height ratio (HWHtR) phenotype and abnormal glucose metabolism in adole...
Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials [0.03%]
钠葡萄糖协同转运蛋白2抑制剂与癌症预后：随机对照试验的系统评价和荟萃分析
Bernardo F Spiazzi,Rafaella A Naibo,Laura F Wayerbacher et al.
Bernardo F Spiazzi et al.
Aims: Concerns regarding breast and bladder cancer risk with Sodium-glucose cotransporter-2 (SGLT2) inhibitors remain controversial and its effect on cancer mortality is unknown. We aim to evaluate the association between...
The relationship between FGF23 and body composition according to albuminuria stage in type 1 diabetes [0.03%]
根据白蛋白尿分期分析1型糖尿病患者FGF23与体组成的关系
Erika B Parente,Aila J Ahola,Anmol Kumar et al.
Erika B Parente et al.
Aims: Fibroblast growth factor 23 (FGF23) and obesity are linked to kidney disease. However, the relationship between FGF23 and body composition is unclear. Associations between FGF23 and body composition were investigate...
Wound healing and healing process in patients with diabetic foot ulcers: A survival analysis study [0.03%]
糖尿病足溃疡患者的伤口愈合及修复过程：一项生存分析研究
M Graça Pereira,Margarida Vilaça,Susana Pedras et al.
M Graça Pereira et al.
Aims: This study aimed to identify demographic, clinical, and psychological contributors to DFU healing and favorable healing process. Methods: ...
Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry? [0.03%]
SGLT2-i和GLP1类似物的致癌安全性问题：我们需要担心吗？
M Gallo,M Monami,A Ragni et al.
M Gallo et al.